Substance use & misuse · 2026
Characterizing Current Nicotine Pouch Use Overall and to Attempt Quitting Tobacco and E-Cigarettes: Analysis of the US Population Assessment of Tobacco and Health (PATH) Study Wave 7 (2022-2023).
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Erinoso Olufemi, Kasza Karin, Pearson Jennifer
Аннотация
BACKGROUND: This study examines the correlates of NP use to attempt quitting tobacco and e-cigarettes, as well as overall NP use patterns (current [past-month], former, and never use) and commonly used NP brands in a nationally representative US adult sample.
METHODS: We used the Population Assessment of Tobacco and Health (PATH) Study Wave-7 data collected between 2022 and 2023 (n = 30,801). We cross-sectionally investigated the correlates of NP-use and their use for quitting and switching tobacco-use. We also report NP brands among current users. Weighted multivariable logistic regression models were used to describe the relationship between NP measures, demographics, and tobacco-use behaviors.
RESULTS: Among US adults, 3.3% had used NPs, while 1.6% and 0.8% were past-year and past-month consumers, respectively. Among individuals who used tobacco and made a quit attempt, 5.9% attempted to quit tobacco with NPs, and 3.6% intended to switch from cigarettes to NPs. Correlates of attempting to quit tobacco with NPs were having people one considered important (vs. none) using NPs (AOR: 4.7; 95% CI: 1.3, 16.3) and past year use (vs. no use) of smoking cessation treatment (AOR:2.9; 95% CI:1.4, 5.9). The most common NP brand used by past-month users was Zyn (57.9%, 95% CI: 50.2, 65.3).
CONCLUSION: Use of nicotine pouches for attempting tobacco cessation or switching was more common among individuals who had engaged with FDA-approved cessation treatments and those with social networks that included pouch users. These findings suggest that NPs are being used alongside traditional cessation treatments and their use may be influenced by social exposure.
METHODS: We used the Population Assessment of Tobacco and Health (PATH) Study Wave-7 data collected between 2022 and 2023 (n = 30,801). We cross-sectionally investigated the correlates of NP-use and their use for quitting and switching tobacco-use. We also report NP brands among current users. Weighted multivariable logistic regression models were used to describe the relationship between NP measures, demographics, and tobacco-use behaviors.
RESULTS: Among US adults, 3.3% had used NPs, while 1.6% and 0.8% were past-year and past-month consumers, respectively. Among individuals who used tobacco and made a quit attempt, 5.9% attempted to quit tobacco with NPs, and 3.6% intended to switch from cigarettes to NPs. Correlates of attempting to quit tobacco with NPs were having people one considered important (vs. none) using NPs (AOR: 4.7; 95% CI: 1.3, 16.3) and past year use (vs. no use) of smoking cessation treatment (AOR:2.9; 95% CI:1.4, 5.9). The most common NP brand used by past-month users was Zyn (57.9%, 95% CI: 50.2, 65.3).
CONCLUSION: Use of nicotine pouches for attempting tobacco cessation or switching was more common among individuals who had engaged with FDA-approved cessation treatments and those with social networks that included pouch users. These findings suggest that NPs are being used alongside traditional cessation treatments and their use may be influenced by social exposure.